Company Overview of Takeda Ireland Limited
Takeda Ireland Limited, a research-based pharmaceutical company, engages in the manufacture of drug products and active pharmaceutical ingredients; and process development, packaging, supply chain, sales, and marketing. The company offers solid oral dosage finished pharmaceuticals. It offers lansoprazole and pioglitazone. The company serves markets in Europe and the United States. Takeda Ireland Limited was formerly known as Grelan Corporation Limited and changed its name to Takeda Ireland Limited in October 1997. The company was incorporated in 1995 and is headquartered in Bray, Ireland. Takeda Ireland Limited operates as a subsidiary of Takeda Pharmaceutical Company Limited.
Bray Business Park
Founded in 1995
353 1 205 0600
353 1 205 0601
Key Executives for Takeda Ireland Limited
Similar Private Companies By Industry
|ADAPT Pharma, Inc.||Europe|
|Bimeda Holdings PLC||Europe|
|Carrick Therapeutics, Ltd.||Europe|
|Consilient Health Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Takeda Ireland Limited, please visit www.takeda.ie. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.